- Home
- CVAC vs NCDL Comparison
CVAC vs NCDL Comparison
Compare CVAC & NCDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- NCDL
- Stock Information
- Founded
- CVAC 2000
- NCDL 2019
- Country
- CVAC Germany
- NCDL United States
- Employees
- CVAC N/A
- NCDL N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- NCDL
- Sector
- CVAC Health Care
- NCDL
- Exchange
- CVAC Nasdaq
- NCDL NYSE
- Market Cap
- CVAC 818.8M
- NCDL 767.2M
- IPO Year
- CVAC 2020
- NCDL N/A
- Fundamental
- Price
- CVAC $3.12
- NCDL $15.18
- Analyst Decision
- CVAC Buy
- NCDL Hold
- Analyst Count
- CVAC 2
- NCDL 3
- Target Price
- CVAC $10.00
- NCDL $16.75
- AVG Volume (30 Days)
- CVAC 717.4K
- NCDL 349.2K
- Earning Date
- CVAC 04-10-2025
- NCDL 05-08-2025
- Dividend Yield
- CVAC N/A
- NCDL 13.83%
- EPS Growth
- CVAC N/A
- NCDL N/A
- EPS
- CVAC 0.75
- NCDL N/A
- Revenue
- CVAC $554,073,921.00
- NCDL N/A
- Revenue This Year
- CVAC N/A
- NCDL N/A
- Revenue Next Year
- CVAC $66.34
- NCDL N/A
- P/E Ratio
- CVAC $4.19
- NCDL N/A
- Revenue Growth
- CVAC 895.54
- NCDL N/A
- 52 Week Low
- CVAC $2.22
- NCDL $14.21
- 52 Week High
- CVAC $5.28
- NCDL $18.05
- Technical
- Relative Strength Index (RSI)
- CVAC 53.48
- NCDL 35.81
- Support Level
- CVAC $3.05
- NCDL $14.21
- Resistance Level
- CVAC $3.02
- NCDL $15.17
- Average True Range (ATR)
- CVAC 0.19
- NCDL 0.59
- MACD
- CVAC 0.06
- NCDL -0.10
- Stochastic Oscillator
- CVAC 79.14
- NCDL 32.66
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About NCDL NUVEEN CHURCHILL DIRECT LENDNG CORP
Nuveen Churchill Direct Lending Corp is a specialty finance company focused predominantly on investing in senior secured loans to private equity-owned U.S. middle market companies. It invest in senior secured loans that typically pay floating interest rates and are senior in the capital structure to junior debt and equity.